# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B. Riley Securities analyst Dave Kang maintains Extreme Networks (NASDAQ:EXTR) with a Buy and raises the price target from $...
Craig-Hallum analyst Christian Schwab maintains Extreme Networks (NASDAQ:EXTR) with a Hold and lowers the price target from ...
Rosenblatt analyst Mike Genovese upgrades Extreme Networks (NASDAQ:EXTR) from Neutral to Buy and raises the price target fro...
Needham analyst Alex Henderson reiterates Extreme Networks (NASDAQ:EXTR) with a Buy and maintains $16.5 price target.
Business Outlook: Extreme's business outlook is based on current expectations. The following statements are forward-lookin...
Business Outlook: Extreme's business outlook is based on current expectations. The following statements are forward-lookin...
Extreme Networks (NASDAQ:EXTR) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...